ClinicalTrials.Veeva

Menu

Tool for Inappropriate Prescription Evaluation: The TaIPE Study

V

Vaud University Hospital Center

Status

Unknown

Conditions

Inappropriate Prescribing

Treatments

Other: PIM-Check
Other: STOPP/START

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

A mono-center, randomized controlled trial will be conducted at the University Hospital of Lausanne. Hospitalized patients will be randomly assigned from the emergency department to two sub-units composing the acute care for elders (ACE) unit. In one subunit, potentially inappropriate prescriptions will be detected and treatment optimized according PIM-Check. In the other, STOPP/START criteria will be independently applied.

Enrollment

464 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients meeting the admission criteria of the acute care for elders (ACE) unit will be eligible.

Exclusion criteria

  • none

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

464 participants in 2 patient groups

PIM-Check group
Experimental group
Treatment:
Other: PIM-Check
STOPP/START group
Active Comparator group
Treatment:
Other: STOPP/START

Trial contacts and locations

1

Loading...

Central trial contact

Akram FARHAT, PharmD, MPH, PhD; Chantal Csajka, PharmD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems